These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14765404)

  • 21. Diabetes management: pumping--a viable alternative.
    Bendelius J
    School Nurse News; 2006 May; 23(3):22, 25. PubMed ID: 16736991
    [No Abstract]   [Full Text] [Related]  

  • 22. Are you ready for the pump? The decision to use an insulin pump is a serious one. Here are a few questions to consider first.
    Ahern JA
    Diabetes Forecast; 2002 Nov; 55(11):60-2. PubMed ID: 14768606
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of continuous subcutaneous insulin infusion in cystic fibrosis patients with cystic fibrosis-related diabetes awaiting transplantation.
    Reali MF; Festini F; Neri AS; Taccetti G; Repetto T; Chiarelli F; Toni S
    J Cyst Fibros; 2006 Jan; 5(1):67-8. PubMed ID: 16233992
    [No Abstract]   [Full Text] [Related]  

  • 24. Should I consider using an insulin pump to take insulin for type 2 diabetes?
    Johns Hopkins Med Lett Health After 50; 2004 Aug; 17(6):8. PubMed ID: 15281175
    [No Abstract]   [Full Text] [Related]  

  • 25. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children: a comparison with multiple daily insulin injections.
    Bin-Abbas B; Al-Ashwal A; Sakati N
    Ann Saudi Med; 2006; 26(4):327-8. PubMed ID: 16891848
    [No Abstract]   [Full Text] [Related]  

  • 26. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of insulin pumps improves the metabolic control in children and adolescents with type 1 diabetes.
    Toni S; Reali MF; Fasulo A; Festini P; Medici A; Martinucci ME
    Arch Dis Child; 2004 Aug; 89(8):796-7. PubMed ID: 15269092
    [No Abstract]   [Full Text] [Related]  

  • 28. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year food and drug administration retrospective study of adverse events.
    Scaramuzza A; Iafusco D; Lombardo F; Rabbone I; Toni S;
    Pediatrics; 2008 Aug; 122(2):473-4; author reply 474. PubMed ID: 18676571
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR
    Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation after one year of portable insulin infusion pumps].
    Solal PC; Bertoglio J; Cupelli C
    Soins; 2004 Sep; (688):21-2. PubMed ID: 15515843
    [No Abstract]   [Full Text] [Related]  

  • 32. Gelling of insulin within an insulin pump reservoir.
    Blumer I
    Diabet Med; 2008 Sep; 25(9):1131. PubMed ID: 18937680
    [No Abstract]   [Full Text] [Related]  

  • 33. [Insulin allergies].
    Sola-Gazagnes A
    Soins; 2007 Apr; (714 Suppl):S2, S4-5. PubMed ID: 17569273
    [No Abstract]   [Full Text] [Related]  

  • 34. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
    Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for insulin management of diabetes in school.
    Silverstein J; Patrick S
    School Nurse News; 2007 Mar; 24(2):9-12. PubMed ID: 17393819
    [No Abstract]   [Full Text] [Related]  

  • 37. The disease does not belong to me.
    Jacobs RW
    Med Econ; 2004 Dec; 81(24):20-1. PubMed ID: 15704337
    [No Abstract]   [Full Text] [Related]  

  • 38. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
    Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
    Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Does insulin glargin (lantus) lead to a progression in diabetic retinopathy?].
    Meyer CH; Kroll P; Hammes HP
    Klin Monbl Augenheilkd; 2005 Apr; 222(4):353-4. PubMed ID: 15844050
    [No Abstract]   [Full Text] [Related]  

  • 40. OmniPod Insulin Management System: patient perceptions, preference, and glycemic control.
    Zisser H; Jovanovic L
    Diabetes Care; 2006 Sep; 29(9):2175. PubMed ID: 16936173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.